MedPath

Effect of Glycerol-Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest

Not Applicable
Completed
Conditions
Hydration
Interventions
Other: Beverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.
Registration Number
NCT06185595
Lead Sponsor
PepsiCo Global R&D
Brief Summary

The objective of this study is to determine the effect of consumption of drinks with varying amounts of glycerol and electrolytes on fluid balance at rest.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Subject is male or female
  • If female, subject is not pregnant
  • Subject is 18-50 years of age, inclusive
  • You are at least recreationally active (engaged in light to moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 30 min at a time)
  • Subject does not smoke (or has quit for at least 6 months)
  • Subject is not taking medication that may interfere with the study (e.g., diuretics)
  • Subject has no health conditions that would interfere with the study as indicated on the general health questionnaire (GHQ), e.g. cardiovascular, renal, or metabolic diseases
  • Subject is willing to avoid alcohol consumption 24 hours prior to visit(s)
  • Subject is willing to fast overnight (~8-12 hours)
  • Subject is willing to refrain from vigorous exercise for 24 hours
  • Subject is willing to eat the exact same food the day prior to each visit to the laboratory
  • Able to speak, write, and read English
  • Provision of written consent to participate
Exclusion Criteria
  • Subject has participated in a clinical trial within the past 30 days
  • Subject has participated in any PepsiCo trial within past 6 months
  • Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk
  • Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ControlBeverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.No sodium, No glycerol
Sodium and Glycerol group 1Beverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.55 mmol/L sodium and 4.6% glycerol
Glycerol onlyBeverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.4.6% glycerol
Sodium only group 1Beverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.55 mmol/L sodium
Sodium only group 2Beverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.27.5 mmol/L sodium
Sodium and Glycerol group 2Beverage. Incomplete block where each participant will complete 3 of the 6 possible glycerol-sodium blends in random order.27.5 mmol/L sodium and 2.3% glycerol
Primary Outcome Measures
NameTimeMethod
Fluid balanceChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90,120 and 180 minutes

Change in body mass to the nearest 0.005 kilogram (kg) using a platform scale

Secondary Outcome Measures
NameTimeMethod
Urine massChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutes

By urine mass scale in grams (g)

Blood pressureChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutes

mmHg by automatic sphygmomanometer

Urine specific gravityChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90,120 and 180 minutes

By USG digital pen refractometer

Blood glucoseChange from baseline (pre-beverage) to post-beverage Time 0, 60 min, 120 min and 180 minutes

By iSTAT Blood Electrolyte and Chemistry Analyzer (CG8+ cartridge) in mg/dL

Subjective measures of gastrointestinal discomfort and headacheChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutes

Visual Analog Scale (VAS) symptom rating of how you feel right now by placing a slash along a 100 millimeter (mm) vertical line anchored from 0 mm (None) to 100 mm (Severe). Fewer symptoms and lower numbers are better.

Fluid retentionChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90,120 and 180 minutes

As a percent (%)

Blood sodiumChange from baseline (pre-beverage) to post-beverage Time 0, 60 min, 120 min and 180 minutes

By iSTAT Blood Electrolyte and Chemistry Analyzer (CG8+ cartridge) in mmol/L

Percent change in plasma volumeChange from baseline (pre-beverage) to post-beverage Time 0, 60 min, 120 min and 180 minutes

Calculated from hematocrit and hemoglobin concentration

Serum glycerol concentrationChange from baseline (pre-beverage) to post-beverage Time 0, 60 min, 120 min and 180 minutes

By Sigma Aldrich glycerol assay kit in mmol/L

Heart rateChange from baseline (pre-beverage) to post-beverage Time 0, 30, 60, 90, 120 and 180 minutes

Beats per minute (bpm) by heart rate monitor

Menstrual cycle phaseFemale participants log menstrual flow throughout study participation. The three study sessions (2-45 days apart) are scheduled to avoid menses and can be completed in the same menstrual cycle, or in 3 different cycles (3 different months) if needed.

Date of last menstrual period by self-report of female participant

Trial Locations

Locations (1)

PepsiCo R&D, Gatorade Sports Science Institute

🇺🇸

Valhalla, New York, United States

© Copyright 2025. All Rights Reserved by MedPath